Track topics on Twitter Track topics that are important to you
Mentice, the world’s leading endovascular simulation solution provider, has announced the release of a new simulation training software for transarterial chemoembolization (TACE). The new software will be showcased at the 2017 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress to be held September 16-20 in Copenhagen, Denmark.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170906005763/en/
Mentice transarterial chemoembolization training software – fluoro (Photo: Business Wire)
TACE is an effective, widely performed therapy performed by interventional radiologists (IRs). It is a minimally invasive procedure for liver cancer that delivers chemotherapy drugs and embolization agents with great accuracy, minimizing side effects for patients. It is however a challenging procedure that involves various sub-techniques, complex anatomies and variant vasculatures requiring the extensive use of radiation. Success of the procedure and impact on cost is tied to the ability to complete it safely and accurately within the permitted radiation doses.
“Conventional apprentice-based training in the clinical practice is costly, resource-intensive and can have an impact on patient safety,” comments Mentice CEO Göran Malmberg. “Our TACE software provides a safe, effective, repeatable and highly realistic solution—allowing IRs to have hands-on training outside of the cath lab.”
The Mentice TACE training solution is based on real-life cases, providing the realism essential for successful training and features an integrated radiation safety module, that provides dose monitoring for patient and staff at all times. The software also features output of metrics, enabling objective assessment of trainees’ progress. “Realistic high-fidelity simulation solutions are very effective for procedures such as TACE,” adds Malmberg. “Trainees can acquire the multi-level skills required to perform the procedure in a dose-dependent, time-effective way, reducing overall costs, while maintaining patient safety.”
Attendees at CIRSE can test the new Mentice TACE training software at the company’s booth (booth RPP1 at the Radiation Protection Pavilion). The software will also be available for testing and demonstrations at ‘The Basics of Chemoembolization for the Liver’ session being held as part of the ‘Principles to Practice: Education and Simulation Skills Training’ program.
To learn more about the new Mentice TACE training software please visit www.mentice.com/tace
To learn more about CIRSE 2017, please visit www.cirse.org
Mentice is the world leader in virtual reality-based interventional medical simulation solutions. Our solutions help healthcare professionals with skills acquisition, continuous development and preprocedural planning—leading to improved productivity and outcomes. Mentice solutions are scientifically validated, and have been specifically developed for healthcare providers and the medical industry. Neurovascular, cardiovascular and peripheral interventions are just some of the areas covered by our systems. Learn more about the features and benefits of Mentice solutions at: www.mentice.com.
Marketing Communications Manager
+46 (0) 31 339 94 94
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...